MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2016 International Congress

June 19-23, 2016. Berlin, Germany.

View by Title View Sessions
View by Date
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Modulation of microglia function in the prion-like spreading of α-synuclein in the murine brain

    W.M. Wemheuer, P. Garcia, E. Konica, A. Masuch, S. Brioschi, K. Biber, A. Weihofen, H. Kollmus, K. Schughart, D. Coowar, R. Balling, M. Buttini (Esch-sur-Alzette, Luxembourg)

  • Modulation of thalamocortical network dynamics via deep brain stimulation in humans with Tourette syndrome

    J.B. Shute, P.J. Rossi, E. Opri, R. Molina, C. De Hemptinne, K.D. Foote, M.S. Okun, A. Gunduz (Gainesville, FL, USA)

  • Moist smokeless tobacco (Snus) use and risk of Parkinson’s disease: Meta-analysis of individual participant data from seven prospective observational studies

    F. Yang, N.L. Pedersen, W. Ye, Z. Liu, M. Norberg, L. Forsgren, Y. Trolle Lagerros, R. Bellocco, L. Alfredsson, A. Knutsson, J.H. Jansson, R. Galanti, A.C.J. Lager, M. Araghi, M. Lundberg, C. Magnusson, K. Wirdefeldt (Stockholm, Sweden)

  • Molecular landscape of Parkinson’s disease reveals a key role for lipids and lipoproteins

    C.J.H.M. Klemann, G.J.M. Martens, M. Sharma, M.B. Martens, O. Isacson, T. Gasser, J.E. Visser, G. Poelmans (Nijmegen, Netherlands)

  • Monitoring dyskinesia severity using wearable sensor data

    J.F. Daneault, F.N. Golabchi, S.I. Lee, G. Vergara-Diaz, G. Ferreira Carvalho, E. Fabara, S. Sapienza, P. Bonato (Charlestown, MA, USA)

  • Monitoring oxidative stress and progression to cell death: From secretome to blood diagnosis

    S.I. Anjo, V.M. Mendes, M. Grãos, B. MAnadas (Cantanhede, Portugal)

  • Monoaminergic biomarkers of cognitive decline in Parkinson’s disease and Lewy body dementia

    S. van der Zee, Y. Vermeiren, T. Aerts, D. van Dam, M.J. Gerritsen, J.M. Spikman, T. van Laar, P.P. de Deyn (Groningen, Netherlands)

  • Morbidity and comorbidity of deep brain stimulation for Parkinson’s disease – A thirteen-years retrospective cohort study

    S.Y. Chen, Y.H. Pan, S.H. Lin (Hualien, Taiwan)

  • Mortality after deep brain stimulation surgery for patients with advanced Parkinson’s disease

    H.S. Ryu, S. You, M.J. Kim, Y.J. Kim, J. Kim, K. Kim, S.J. Chung (Seoul, Korea)

  • Motivators and barriers to participation in exercise in Parkinson’s disease

    M. Afshari, Y. Kianirad, D. Bega (Chicago, IL, USA)

  • « Previous Page
  • 1
  • …
  • 121
  • 122
  • 123
  • 124
  • 125
  • …
  • 207
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
  • #26133 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley